91:@0.890196:0.957873:0.906548:0.957873:0.906548:0.938882:0.890196:0.938882:0.007761:0.008591
4:@0.941813:0.373065:0.963291:0.373065:0.963291:0.325587:0.941813:0.325587:0.021478
A MULTI-PLATFORM REFERENCE FOR SOMATIC STRUCTURAL VARIATION DETECTION:@0.405458:0.064721:0.882352:0.064721:0.882352:0.047603:0.405458:0.047603:0.007732:0.002988:0.011112:0.008367:0.005360:0.006387:0.003511:0.005155:0.008050:0.006481:0.007095:0.006387:0.006593:0.008442:0.008423:0.011112:0.002988:0.008423:0.006985:0.006593:0.006985:0.008423:0.006985:0.008759:0.008255:0.006985:0.002988:0.006593:0.008442:0.008423:0.002988:0.007807:0.008442:0.011112:0.007093:0.006387:0.003511:0.008255:0.002988:0.007732:0.006387:0.008367:0.008367:0.008180:0.006387:0.008367:0.008423:0.007919:0.006294:0.002800:0.006966:0.007919:0.008423:0.003511:0.007097:0.006387:0.003511:0.008442:0.008759:0.002988:0.008423:0.006985:0.006387:0.006985:0.008178:0.006387:0.003511:0.008442:0.008759
Abstract:@0.147059:0.126494:0.242873:0.126494:0.242873:0.098384:0.147059:0.098384:0.012318:0.012812:0.012028:0.010343:0.013103:0.012144:0.012725:0.010343
Accurate detection of somatic structural variation (SV) in cancer genomes remains a :@0.147059:0.166727:0.886555:0.166727:0.886555:0.146354:0.147059:0.146354:0.014335:0.008994:0.009108:0.011413:0.007898:0.008811:0.006209:0.009039:0.006711:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.006711:0.010843:0.006209:0.006711:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.006711:0.007510:0.006437:0.007967:0.011345:0.009108:0.006163:0.011413:0.007898:0.009405:0.005250:0.006711:0.009838:0.009085:0.007807:0.005798:0.008811:0.006437:0.005547:0.010843:0.011756:0.006711:0.006939:0.010112:0.015089:0.006939:0.006711:0.005615:0.011756:0.006711:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.006711:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007670:0.006711:0.007442:0.009039:0.017577:0.009085:0.005615:0.011619:0.007670:0.006711:0.009291:0.004109
challenging problem. This is in part due to the lack of high-quality gold standard datasets :@0.147059:0.187306:0.886441:0.187306:0.886441:0.166933:0.147059:0.166933:0.008765:0.011391:0.009405:0.005387:0.005182:0.009039:0.011459:0.009861:0.005615:0.011459:0.009861:0.003538:0.011071:0.007442:0.010957:0.010911:0.005182:0.009039:0.017645:0.004497:0.003538:0.011470:0.011470:0.005615:0.007670:0.003538:0.005615:0.007670:0.003538:0.005615:0.011756:0.003538:0.011368:0.009085:0.007967:0.006437:0.003538:0.011048:0.011345:0.009039:0.003538:0.006209:0.011048:0.003538:0.006620:0.011299:0.009039:0.003538:0.005433:0.009291:0.008765:0.010523:0.003538:0.010843:0.006209:0.003538:0.011459:0.005615:0.009930:0.011459:0.007533:0.010703:0.011596:0.009405:0.005250:0.005273:0.006437:0.009724:0.003538:0.009656:0.010934:0.005182:0.011391:0.003538:0.007512:0.006551:0.009085:0.011596:0.011573:0.009085:0.007442:0.011391:0.003538:0.011573:0.008811:0.006551:0.009291:0.007875:0.009131:0.006437:0.007670:0.004109
that enable the benchmarking of experimental approaches and bioinformatic analysis :@0.147059:0.207885:0.886441:0.207885:0.886441:0.187512:0.147059:0.187512:0.006620:0.011391:0.008811:0.006437:0.006277:0.009039:0.011687:0.009108:0.010911:0.005182:0.009039:0.006277:0.006620:0.011299:0.009039:0.006277:0.011254:0.009039:0.011596:0.008765:0.011459:0.017577:0.009085:0.007601:0.010706:0.005615:0.011459:0.009861:0.006277:0.010843:0.006209:0.006277:0.009108:0.010089:0.011505:0.009039:0.007807:0.005615:0.017485:0.009039:0.011391:0.006551:0.009405:0.005250:0.006277:0.008811:0.011048:0.011069:0.007444:0.011137:0.009291:0.008768:0.011299:0.009039:0.007670:0.006277:0.009085:0.011596:0.011391:0.006277:0.010820:0.005547:0.010843:0.005615:0.011756:0.006026:0.010843:0.007807:0.017577:0.008811:0.006437:0.005547:0.008994:0.006277:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004109
pipelines for comprehensive somatic SV detection. Here, we approached this challenge :@0.147059:0.228463:0.886535:0.228463:0.886535:0.208091:0.147059:0.208091:0.011071:0.005273:0.011505:0.008948:0.005250:0.005615:0.011596:0.009039:0.007670:0.005159:0.006026:0.010843:0.007807:0.005159:0.008994:0.010843:0.017282:0.011069:0.007442:0.008948:0.011302:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.005159:0.007873:0.010845:0.017577:0.008811:0.006437:0.005547:0.008994:0.005159:0.010112:0.015089:0.005159:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.004497:0.005159:0.016207:0.009039:0.007442:0.008743:0.004497:0.005159:0.014518:0.009039:0.005159:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011299:0.009108:0.011391:0.005159:0.006620:0.011459:0.005615:0.007670:0.005159:0.008765:0.011391:0.009405:0.005387:0.005182:0.009039:0.011459:0.009656:0.009039:0.004109
by genome-wide somatic SV analysis of the paired melanoma and normal lympho-:@0.147059:0.249042:0.882353:0.249042:0.882353:0.228669:0.147059:0.228669:0.010843:0.009724:0.007784:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007533:0.014723:0.005547:0.011322:0.009039:0.007784:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.007784:0.010112:0.015089:0.007784:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.007784:0.010843:0.006209:0.007784:0.006620:0.011299:0.009039:0.007784:0.011368:0.009085:0.005615:0.007442:0.009108:0.011391:0.007784:0.017485:0.008948:0.005433:0.009085:0.011596:0.010843:0.017577:0.009291:0.007784:0.009085:0.011596:0.011391:0.007784:0.011598:0.010840:0.007807:0.017577:0.009402:0.005250:0.007784:0.005182:0.009724:0.017282:0.011160:0.011302:0.011023:0.007533
blastoid COLO829 cell lines using four different technologies: Illumina HiSeq, Oxford :@0.147059:0.269621:0.886544:0.269621:0.886544:0.249248:0.147059:0.249248:0.010911:0.005433:0.009291:0.007510:0.006209:0.010843:0.005547:0.011391:0.005319:0.014746:0.016047:0.011528:0.016412:0.010432:0.010432:0.010432:0.005307:0.008994:0.008948:0.005387:0.005250:0.005319:0.005250:0.005615:0.011596:0.009039:0.007670:0.005319:0.011413:0.007601:0.005615:0.011459:0.009861:0.005319:0.006026:0.010820:0.011413:0.007807:0.005319:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.005319:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.004497:0.005319:0.007190:0.005387:0.004908:0.011413:0.017645:0.005615:0.011687:0.009291:0.005319:0.016481:0.005615:0.010592:0.009106:0.010729:0.004497:0.005319:0.016298:0.010089:0.006026:0.010845:0.007442:0.011391:0.004109
Nanopore, Pacific Biosciences and 10x Genomics. Based on the evidence from multiple :@0.147059:0.290200:0.886466:0.290200:0.886466:0.269827:0.147059:0.269827:0.015545:0.009085:0.011596:0.010820:0.011505:0.010843:0.007442:0.008743:0.004497:0.004474:0.011413:0.009291:0.008994:0.005615:0.005684:0.005615:0.008994:0.004474:0.012486:0.005547:0.010957:0.007875:0.008994:0.005547:0.009039:0.011596:0.008994:0.009039:0.007670:0.004474:0.009085:0.011596:0.011391:0.004474:0.010432:0.010432:0.010089:0.004474:0.015819:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007670:0.004497:0.004474:0.012874:0.009291:0.007875:0.009108:0.011391:0.004474:0.010843:0.011756:0.004474:0.006620:0.011299:0.009039:0.004474:0.009336:0.009838:0.005547:0.011322:0.009039:0.011598:0.008994:0.009039:0.004474:0.006414:0.007442:0.010843:0.017645:0.004474:0.017280:0.011550:0.004908:0.006437:0.005273:0.011162:0.005182:0.009039:0.004109
technologies combined with extensive experimental validation, including Bionano opti-:@0.147059:0.310778:0.882353:0.310778:0.882353:0.290405:0.147059:0.290405:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.003881:0.008994:0.010843:0.017394:0.010820:0.005615:0.011596:0.009108:0.011391:0.003881:0.014723:0.005273:0.006620:0.011459:0.003881:0.009108:0.010089:0.006209:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.003881:0.009108:0.010089:0.011502:0.009039:0.007807:0.005615:0.017485:0.009039:0.011391:0.006551:0.009405:0.005250:0.003881:0.009838:0.009405:0.005250:0.005547:0.011573:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.003881:0.005615:0.011596:0.008765:0.004908:0.011345:0.011391:0.005615:0.011459:0.009861:0.003881:0.012486:0.005547:0.010843:0.011687:0.009085:0.011596:0.011048:0.003881:0.010820:0.011048:0.006437:0.005638:0.007533
cal mapping data and targeted detection of candidate breakpoint junctions, we compiled :@0.147059:0.331357:0.886464:0.331357:0.886464:0.310984:0.147059:0.310984:0.009108:0.009405:0.005250:0.003661:0.017577:0.008811:0.011048:0.011071:0.005615:0.011459:0.009861:0.003664:0.011573:0.008811:0.006551:0.009291:0.003661:0.009085:0.011596:0.011391:0.003664:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.003661:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.003664:0.010843:0.006209:0.003661:0.009108:0.009085:0.011596:0.011391:0.005547:0.011573:0.008811:0.006209:0.009039:0.003661:0.010822:0.007442:0.009288:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.003664:0.004953:0.011413:0.011596:0.009108:0.006437:0.005547:0.010843:0.011619:0.007670:0.004497:0.003664:0.014518:0.009039:0.003664:0.008994:0.010843:0.017280:0.011071:0.005752:0.005182:0.009108:0.011391:0.004109
a comprehensive set of true somatic SVs, comprising all SV types. We demonstrate the :@0.147059:0.351936:0.886462:0.351936:0.886462:0.331563:0.147059:0.331563:0.009291:0.005216:0.008994:0.010843:0.017280:0.011071:0.007442:0.008948:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.005216:0.007875:0.009128:0.006437:0.005216:0.010843:0.006209:0.005216:0.006437:0.007964:0.011347:0.009039:0.005214:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.005216:0.010112:0.015089:0.007670:0.004497:0.005214:0.008994:0.010843:0.017280:0.011071:0.007807:0.005615:0.007601:0.005615:0.011459:0.009861:0.005216:0.009405:0.005385:0.005250:0.005216:0.010112:0.015089:0.005216:0.006437:0.009724:0.011502:0.009039:0.007670:0.004497:0.005216:0.018649:0.009039:0.005214:0.011324:0.009039:0.017485:0.010843:0.011619:0.007510:0.006437:0.007898:0.008811:0.006209:0.009039:0.005214:0.006620:0.011299:0.009039:0.004109
utility of this resource by determining the SV detection performance of each technology :@0.147059:0.372514:0.886373:0.372514:0.886373:0.352141:0.147059:0.352141:0.011071:0.006437:0.005752:0.005250:0.005273:0.006437:0.009724:0.003949:0.010843:0.006209:0.003949:0.006617:0.011459:0.005615:0.007670:0.003949:0.007442:0.009039:0.007875:0.010818:0.011413:0.007444:0.008994:0.009039:0.003949:0.010843:0.009724:0.003949:0.011322:0.009131:0.006209:0.009039:0.007807:0.017645:0.005615:0.011756:0.005615:0.011459:0.009861:0.003949:0.006620:0.011299:0.009039:0.003949:0.010112:0.015089:0.003949:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.003949:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017577:0.009085:0.011596:0.008994:0.009039:0.003949:0.010843:0.006209:0.003949:0.009291:0.009291:0.008765:0.011459:0.003949:0.006209:0.009108:0.008765:0.011459:0.011598:0.010932:0.005184:0.011048:0.010546:0.009724:0.004109
as a function of tumor purity and sequence depth, highlighting the importance of as-:@0.147059:0.393093:0.882353:0.393093:0.882353:0.372720:0.147059:0.372720:0.009291:0.007670:0.006072:0.009291:0.006072:0.006369:0.011413:0.011596:0.009108:0.006437:0.005547:0.010843:0.011756:0.006072:0.010843:0.006209:0.006072:0.006163:0.011413:0.017485:0.010843:0.007807:0.006072:0.011048:0.011413:0.007807:0.005273:0.006437:0.009724:0.006072:0.009085:0.011596:0.011391:0.006072:0.007875:0.009108:0.010703:0.011345:0.009039:0.011598:0.008994:0.009039:0.006072:0.011324:0.009128:0.011048:0.006620:0.011459:0.004497:0.006072:0.011459:0.005615:0.009930:0.011573:0.005250:0.005615:0.009930:0.011094:0.006437:0.005615:0.011459:0.009861:0.006072:0.006620:0.011302:0.009039:0.006072:0.005615:0.017280:0.011505:0.010843:0.007967:0.006551:0.009085:0.011596:0.008994:0.009039:0.006072:0.010843:0.006209:0.006072:0.009291:0.007574:0.007533
sessing these parameters in cancer genomics projects and data analysis tool evaluation. :@0.147059:0.413672:0.886510:0.413672:0.886510:0.393299:0.147059:0.393299:0.007875:0.009039:0.007533:0.007601:0.005615:0.011459:0.009861:0.005090:0.006620:0.011299:0.009039:0.007875:0.009039:0.005090:0.011368:0.009085:0.007898:0.009085:0.017485:0.009131:0.006209:0.009039:0.007624:0.007670:0.005090:0.005615:0.011756:0.005090:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.005090:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007670:0.005090:0.011071:0.007442:0.010820:0.005341:0.009108:0.009106:0.006437:0.007670:0.005090:0.009085:0.011596:0.011391:0.005090:0.011573:0.008811:0.006551:0.009291:0.005090:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.005090:0.006209:0.011276:0.010934:0.005250:0.005090:0.009336:0.009838:0.009405:0.004908:0.011596:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109
The reference truth somatic SV dataset as well as the underlying raw multi-platform se-:@0.147059:0.434250:0.882353:0.434250:0.882353:0.413878:0.147059:0.413878:0.011470:0.011311:0.009039:0.004611:0.007442:0.009039:0.006026:0.009039:0.007442:0.009039:0.011596:0.008994:0.009039:0.004611:0.006437:0.007967:0.011071:0.006620:0.011459:0.004611:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.004611:0.010112:0.015089:0.004611:0.011573:0.008811:0.006551:0.009291:0.007875:0.009128:0.006437:0.004611:0.009291:0.007670:0.004611:0.014518:0.008948:0.005387:0.005250:0.004611:0.009291:0.007670:0.004611:0.006620:0.011299:0.009039:0.004611:0.011413:0.011596:0.011322:0.009039:0.007601:0.005182:0.009724:0.005615:0.011459:0.009861:0.004611:0.007898:0.008925:0.014723:0.004611:0.017280:0.011550:0.004908:0.006437:0.005615:0.007533:0.011162:0.005433:0.008811:0.006437:0.006026:0.010843:0.007807:0.017645:0.004611:0.007875:0.009131:0.007533
quencing data are freely available and are an important resource for community somatic :@0.147059:0.454829:0.886393:0.454829:0.886393:0.434456:0.147059:0.434456:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.003949:0.011573:0.008811:0.006551:0.009291:0.003949:0.009085:0.007442:0.009039:0.003949:0.006414:0.007442:0.009108:0.008948:0.005182:0.009724:0.003949:0.008925:0.009838:0.009085:0.005752:0.005433:0.009108:0.010911:0.005182:0.009039:0.003949:0.009085:0.011596:0.011391:0.003949:0.009085:0.007442:0.009039:0.003949:0.009085:0.011756:0.003949:0.005615:0.017280:0.011505:0.010843:0.007967:0.006549:0.009087:0.011391:0.006437:0.003949:0.007442:0.009039:0.007875:0.010820:0.011413:0.007442:0.008994:0.009039:0.003949:0.006024:0.010845:0.007807:0.003949:0.008994:0.010843:0.017645:0.017280:0.011413:0.011756:0.005273:0.006437:0.009724:0.003949:0.007873:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.004109
benchmarking efforts.:@0.147059:0.475408:0.333394:0.475408:0.333394:0.455035:0.147059:0.455035:0.011254:0.009039:0.011596:0.008765:0.011459:0.017577:0.009085:0.007601:0.010706:0.005615:0.011459:0.009861:0.004109:0.009039:0.005969:0.005787:0.010843:0.007967:0.006437:0.007670:0.004497